Is CDKN2A p.Ala19= (c.57C>G) pathogenic?

CDKN2A p.Ala19= (c.57C>G) is classified Benign/Likely benign in CDKN2A (ClinVar, Multiple submitters, 3 submitters; last evaluated 2026-01-19). Very rare (popmax 8.48e-05%, nfe); Associated with familial melanoma.

What condition is associated with CDKN2A p.Ala19= (c.57C>G)?

CDKN2A p.Ala19= (c.57C>G) is associated with familial melanoma, melanoma-pancreatic cancer syndrome, hereditary neoplastic syndrome (ClinVar).

How common is CDKN2A p.Ala19= (c.57C>G) in the general population?

CDKN2A p.Ala19= (c.57C>G) is very rare (popmax 8.48e-05%, nfe) (gnomAD).

How is Familial melanoma inherited?

Typically Autosomal dominant, Multigenic/multifactorial (Orphanet). A genetic counselor can assess individual risk for a family.

CDKN2A p.Ala19=

c.57C>G · rs1060504186 · VCV1077933

Benign/Likely benign Multiple submitters

Classification

Benign/Likely benign

ClinVar

Review

Multiple submitters ★★☆☆

ClinVar · 3 submitters

gnomAD v4.1

Rare

very rare (popmax 8.48e-05%, nfe)

Conditions

familial melanoma

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP -6.4	GERP -4.1
Overall
CADD	3.164	PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 8.48e-05% European (non-Finnish) · 1/1,179,032 alleles

Overall 6.87e-05% 1/1,455,558 alleles · very rare

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: CDKN2A
Protein: p.Ala19=
Coding: c.57C>G
MANE Select: NM_000077
dbSNP: rs1060504186
Type: single nucleotide variant
Location: chr9:21974771 (GRCh38)
Gene constraint: LOEUF 0.791 · pLI 0.62 · ClinGen HI 3/3 (gnomAD)
Structure: AlphaFold pLDDT 77.02 · 5 PDB
Residue 19: an α-helix; a UniProt-annotated variant site (in cmm2; loss of cdk4 binding); the 'interaction with cdk5rap3 and mdm2' region

Full CDKN2A gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

familial melanoma — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: melanoma-pancreatic cancer syndrome hereditary neoplastic syndrome

For Familial melanoma (Orphanet):

Inheritance: Autosomal dominant, Multigenic/multifactorial
Onset: Adult
Prevalence: 1-9 / 100 000 (Europe)

Similar variants

CDKN2A p.Arg19Gln Uncertain significance ★★ same residue
CDKN2A p.Arg19Leu Uncertain significance ★★ same residue
CDKN2A p.Arg19Ter Likely pathogenic ★ same residue
CDKN2A p.Ala19Asp Uncertain significance ★ ⚠ same residue
CDKN2A p.Ala19Ser Uncertain significance ★ ⚠ same residue
CDKN2A p.Ala19Thr Uncertain significance ★ ⚠ same residue
CDKN2A p.Arg19Pro Uncertain significance ★ same residue
CDKN2A p.Arg19= Likely benign ★ same residue

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cdkn2a-p-ala19 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown